Home » Topics » Drug design, drug delivery and technologies, BioWorld Science

Drug design, drug delivery and technologies, BioWorld Science
RSS

Terrapin and Pharmagene enter drug screening alliance

Nov. 28, 1997

Genetronics cleared to start electroporation therapy phase II trial in U.S.

Nov. 27, 1997

Electroporation for gene delivery into tumor cells: in vivo results

Nov. 26, 1997

Myriad Genetics and Bayer join forces to develop dementia and depression therapies

Nov. 24, 1997

Pharmacopeia/Texas Biotechnology drug discovery collaboration

Nov. 21, 1997

Notice of allowance issued for DepoTech's drug delivery patent

Nov. 21, 1997

Andrx seeks patent coverage for new drug delivery system

Nov. 20, 1997

Sankyo and ArQule enter drug discovery collaboration

Nov. 19, 1997

LXR's patented drug screening technology yields two novel apoptosis-suppressing agents

Nov. 18, 1997

Second drug from Inhale/Baxter collaboration enters clinical testing

Nov. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 3, 2026